|
|||||
|
|

Electronic components manufacturer Knowles (NYSE:KN) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 13.8% year on year to $162.2 million. On top of that, next quarter’s revenue guidance ($148 million at the midpoint) was surprisingly good and 3.4% above what analysts were expecting. Its non-GAAP profit of $0.36 per share was in line with analysts’ consensus estimates.
Is now the time to buy KN? Find out in our full research report (it’s free for active Edge members).
Knowles delivered a positive Q4, with revenue growth fueled by broad-based demand across its Precision Devices and Medtech & Specialty Audio segments. Management attributed the results to normalized channel inventories and new design wins in high-growth markets such as medical, defense, and energy. CEO Jeffrey Niew emphasized the company’s ability to leverage custom-engineered solutions and close customer relationships to secure next-generation projects. He pointed to strong bookings and a healthy backlog, noting, “Our customers continue to choose our innovative and differentiated solutions, resulting in a robust pipeline of new design wins.”
Looking forward, Knowles’ guidance reflects expectations for continued organic growth, particularly as production ramps for a large energy order and specialty film products. Management highlighted the expansion of its customer base in both energy and medical applications, as well as ongoing investments in capacity and automation. CFO John Anderson stated, “We have a robust backlog and increased order activity, which gives me confidence in our ability to continue to achieve revenue, earnings, and cash flow growth.” The company remains focused on scaling new products, executing on its specialty film line, and pursuing both organic and inorganic growth opportunities.
Management credited Q4’s performance to strong execution in core end markets, successful new product ramps, and ongoing strength in both direct and distribution channels.
Knowles expects its growth trajectory to continue, driven by energy market ramps, medical design wins, and sustained demand across diversified end markets.
Over the next few quarters, our analysts will be watching (1) the successful ramp of specialty film production for the large energy order, (2) evidence of sustained design win momentum in medical and defense applications, and (3) the company’s ability to maintain or expand margins as capacity utilization increases. The pace of adoption in new industrial applications and management’s execution on capacity expansion will also be important indicators of ongoing progress.
Knowles currently trades at $24.99, in line with $24.74 just before the earnings. Is there an opportunity in the stock?Find out in our full research report (it’s free).
Your portfolio can’t afford to be based on yesterday’s story. The risk in a handful of heavily crowded stocks is rising daily.
The names generating the next wave of massive growth are right here in our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 244% over the last five years (as of June 30, 2025).
Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.
| Feb-12 | |
| Feb-08 | |
| Feb-06 | |
| Feb-06 | |
| Feb-06 | |
| Feb-05 | |
| Feb-05 | |
| Feb-05 | |
| Feb-03 | |
| Jan-06 | |
| Jan-01 | |
| Dec-03 | |
| Dec-02 | |
| Nov-21 | |
| Nov-13 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite